Skip to content
sellModerate cluster of 3

Bryan Dechairo sold $340k of WGS

Chief Operating Officer at GeneDx Holdings Corp.. 3,413 shares at an average of $99.53, traded Feb 2, 2026, filed Feb 3, 2026.

Warning score
45
Value
$340k
3,413 shares
Holdings after
5,961
-36% from before
From 52-week low
+76%
low $56.36, close $99.01
From 52-week high
-41%
high $167.51, as of Feb 2, 2026

Score components

  • Role
    COO
    +20
  • Trade size
    $340k at market
    +15
  • Share of holdings sold
    Sold 36% of holdings
    +10
  • Cluster
    3 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

WGSOct 9, 2026 · close 67.33
Since filing Feb 3, 2026: -29.3%SPY +13.8% · excess -43.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0002051759-26-000005, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Feb 1, 2026MOption exercise
Class A Common Stock
+9,374$0.00$09,374Feb 3, 2026
Feb 2, 2026SOpen-market sale
Class A Common Stock
-93$96.77$8,9999,281Feb 3, 2026
Feb 2, 2026SOpen-market sale
Class A Common Stock
-492$98.61$49k8,789Feb 3, 2026
Feb 2, 2026SOpen-market sale
Class A Common Stock
-1,662$99.40$165k7,127Feb 3, 2026
Feb 2, 2026SOpen-market sale
Class A Common Stock
-1,166$100.31$117k5,961Feb 3, 2026
Feb 1, 2026MOption exercise
Restricted Stock Unitderivative
-9,374$0.00$028,123Feb 3, 2026

Related signals

Other insiders at GeneDx Holdings Corp. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
30Weak
WGSsell 2
GeneDx Holdings Corp.
Kevin Feeley
CHIEF FINANCIAL OFFICER
$364k
3,728 shares
-8%
43Moderate
WGSsell 2
GeneDx Holdings Corp.
Katherine Stueland
CHIEF EXECUTIVE OFFICER
$1.0M
10,501 shares
-8%
25Weak
WGSsell 2
GeneDx Holdings Corp.
Kevin Feeley
CHIEF FINANCIAL OFFICER
$108k
1,285 shares
-3%
32Weak
WGSsell 2
GeneDx Holdings Corp.
Katherine Stueland
CHIEF EXECUTIVE OFFICER
$311k
3,692 shares
-3%
20Weak
WGSsell 2
GeneDx Holdings Corp.
Kevin Feeley
CHIEF FINANCIAL OFFICER
$31k
372 shares
-1%
39Weak
WGSsell 2
GeneDx Holdings Corp.
Kevin Feeley
CHIEF FINANCIAL OFFICER
$557k
8,818 shares
-20%
53Moderate
WGSsell 2
GeneDx Holdings Corp.
Katherine Stueland
CHIEF EXECUTIVE OFFICER
$3.0M
46,933 shares
-34%
37Weak
WGSsell 2
GeneDx Holdings Corp.
Kevin Feeley
CHIEF FINANCIAL OFFICER
$438k
5,706 shares
-17%
48Moderate
WGSsell 2
GeneDx Holdings Corp.
Katherine Stueland
CHIEF EXECUTIVE OFFICER
$1.3M
17,179 shares
-23%
25Weak
WGSsell 2
GeneDx Holdings Corp.
Kevin Feeley
CHIEF FINANCIAL OFFICER
$111k
1,280 shares
-6%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Bryan Dechairo sold $340k of WGS | InsiderTell